Doctor profile · Federal record
Dr. Linli Xuan, MD
Hematology & Oncology Physician · Medical Oncology Physician · Olympia, WA
- NPI 1609808831
- MIPS 75.0 / 100 · 2023
- 20 yrs on file
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
420 McPhee RD Sw, Suite A
Olympia, WA 985025014
(360) 352-2900
fax (360) 352-2916 - Mailing address
-
Po Box 749495
Atlanta, GA 303749495
Credentials & registration
- NPI registered
- July 2006 — 20 yrs on file
- Profile last updated
- January 12, 2023
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Washington #MD00043519
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609808831. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
100,687
Distinct HCPCS
10
Medicare allowed
$1,326,980
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 36,720 | 35 | $0 | |
J0897 |
Injection, denosumab, 1 mg | 24,600 | 156 | $23 | |
J1442 |
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 9,720 | 16 | $1 | |
J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units | 5,741 | 25 | $7 | |
J0185 |
Injection, aprepitant, 1 mg | 3,900 | 13 | $2 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 3,630 | 15 | $33 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,768 | 44 | $0 | |
36415 |
Insertion of needle into vein for collection of blood sample | 2,036 | 609 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,982 | 547 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,707 | 533 | $127 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 1,793. This provider delivers 56× the peer median.Open Payments
Industry payments received
All-time total
$3,395
Transactions
79
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $818.99 | |
| ABBVIE INC. | 13 | $326.42 | |
| AstraZeneca Pharmaceuticals LP | 10 | $249.40 | |
| Janssen Biotech, Inc. | 5 | $205.08 | |
| Stemline Therapeutics Inc. | 4 | $160.53 | |
| Celgene Corporation | 6 | $143.15 | |
| Merck Sharp & Dohme LLC | 6 | $135.25 | |
| PFIZER INC. | 6 | $127.05 | |
| BeiGene USA, Inc. | 3 | $73.64 | |
| Tempus AI, Inc | 2 | $73.64 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69.08 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $64.72 | |
| Ipsen Biopharmaceuticals, Inc | 2 | $63.44 | |
| Lilly USA, LLC | 3 | $63.34 | |
| GlaxoSmithKline, LLC. | 2 | $62.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
483
Patients
88
Total drug cost
$468,342
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 65 | 21 | $2,267 |
| Gabapentin | Generic | 46 | 12 | $334 |
| Losartan Potassium | Generic | 39 | 11 | $658 |
| Prednisone | Generic | 39 | 11 | $358 |
| Abiraterone Acetate | Generic | 36 | 0 | $80,724 |
| Xarelto (Rivaroxaban) | Brand | 34 | 0 | $25,403 |
| Tamoxifen Citrate | Generic | 31 | 0 | $1,198 |
| Ondansetron Odt (Ondansetron) | Brand | 29 | 20 | $293 |
| Anastrozole | Generic | 28 | 0 | $654 |
| Hydroxyurea | Generic | 25 | 0 | $1,130 |
Frequently asked questions
What is Dr. Linli Xuan's medical specialty?
Dr. Linli Xuan practices Hematology & Oncology Physician in Olympia, WA.
Where does Dr. Linli Xuan practice?
Dr. Linli Xuan practices at 420 McPhee RD Sw, Olympia, WA 985025014. Office phone: 3603522900.
What is Dr. Linli Xuan's NPI?
Dr. Linli Xuan's National Provider Identifier (NPI) is 1609808831, issued by NPPES.
What procedures does Dr. Linli Xuan commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, denosumab, 1 mg (HCPCS J0897); Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram (HCPCS J1442). Source: CMS Medicare Physician & Other Practitioners file.